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Aim and Hypothesis: Cytomegalovirus (CMV) is the most commonly 
encountered cause of viral intrauterine infections. As primary and recurrent CMV infections 
in pregnancy can lead to severe conditions in both the mother and the fetus it should be 
described properly in order to take precautions and treat these infections. In this study, we 
aimed to determine the ratio of CMV seroconversion and the presence of CMV DNA in 
amniotic fluids from risky pregnant women in Aydın region.  
Method: During the period between March 2006 to December 2008 in Laboratory 
of Department of Microbiology and Clinical Microbiology, Adnan Menderes University 
Faculty of Medicine, CMV-spesific IgG and IgM were determined by ELISA (Meddens 
Diagnostics BV) in 100 pregnant women who were performed amniocenthesis for a variety of 
obstetric indications at 17 to 21 weeks of gestation. Avidity index was studied by  ELISA 
(Radim SpA, Pomezia-Roma-İtalya). The pregnant women were classified as seropositive or 
not according to the presence of CMV-spesific IgG and IgM and a primary or a reccurent 
CMV infection according to avidity index of anti-CMV IgG. CMV DNA was investigated in 
the amniotic fluid and blood samples by real-time (RT) polymerase chain reaction (PCR) 
assay.  
Results: The rate of seropositivity was found as 95 % and seronegativity as 5 % 
in pregnant women and the fetal infection rate was found 1 %. The only a pregnant women 
was positive for CMV DNA by RT PCR and high avidity index. The infant whom mother 
determined CMV DNA in her amniotic fluid showed high avidity index. The another pregnant 
woman was found CMV IgM positive and also high avidity index but not detected CMV 
DNA in her amniotic fluid. CMV DNA was not found in any of the blood samples.  
Conclusion: We concluded that the fetal CMV infection rate is very low due to 
high maternal seropositivity in our region. During the pregnancy, serological screening of 
CMV in mother should be supported with avidity test whwn seroconversion occured or CMV 
IgM antibody positivity determined. In acute infections cases, CMV quantitative PCR and/or 
cell culture assays can be applied to amniotic fluid in the 21-22th weeks of pregnancy. As a 
result, the pregnant women had risk factors should be screened in terms of CMV infection.  
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